Sectors
Capabilities
Specialisms
CellVoyant, an AI-first biotech, was ready to launch with a bold mission: accelerate the development of cell therapies through AI. But entering a competitive and crowded category demanded clarity, authority and an impactful story. Zero brand awareness. Limited public proof points. A complex technology to explain...
CellVoyant needed to make a compelling first impression on investors, pharma partners, and top-tier talent.
We defined CellVoyant’s mission and crafted a concise and media-ready story that translated technical ambition into human impact – using AI to accelerate the development of new cell therapies. We conducted media training with Rory Cellan-Jones, the former BBC Technology Editor turned health commentator, to sharpen the team’s narrative delivery and built their confidence in telling the story in an authentic and integral voice.
Exclusive media pitching at launch
The launch hinged on an exclusive seed funding story with Sifted, which we used as a springboard to engage biotech and business titles.
Extending the thought leadership with CEO profiling
The programme evolved into a sustained thought leadership brief, which involved:
We continually positioned Rafael Carazo Salas, CellVoyant’s Founder as a leading voice on the commercial and clinical potential of AI in cell therapy, creating a platform for him to voice his opinions in front of investors and industry peers, while raising the brand profile with key audiences.
See all